Our result thus encourages not only replication efforts of the two mutations in relation to fasting GH concentration but also studies in much larger cohorts to test if the genetic elevation of GH mediated by stop codons of MYO1A and ZNF77 could be replicated and if it would be associated with risk of cardiovascular disease and mortality. This evidence concerns the gene GH1 and cardiovascular disorder.